Healthcare & Life Sciences: Drug Pricing Digest - February 2022

Latham & Watkins LLP
Contact

Drug Pricing Initiatives: Discussion continues regarding pathways to Senate passage of H.R. 5376 (the Build Back Better Act, or BBBA). Potential approaches include a reduced or modified version of the BBBA, although details and timing remain unclear. In a speech on Feb. 10, 2022, President Biden urged passage of the drug pricing portions of the BBBA, stating that “bringing down the cost of prescription drugs is an easy thing for us to do” and could be “done legally with the stroke of a pen.” Meanwhile, Senator Bernie Sanders and Senator Amy Klobuchar introduced the Cutting Medicare Prescription Drug Prices in Half Act, which would cap reimbursement under Medicare Part B and Part D for all drugs at the lower of the amount paid by the Secretary of Veterans Affairs to procure the drug, or the amount paid to procure the drug through the Federal Supply Schedule of the General Services Administration.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Latham & Watkins LLP | Attorney Advertising

Written by:

Latham & Watkins LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Latham & Watkins LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide